FDA Inspection 1182359 — Sanofi Pasteur Limited
The FDA completed an inspection of Sanofi Pasteur Limited on October 28, 2022 in North York. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 28, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- North York (Canada)